C066-0833 Screening compound: 2,3-bis(4-methoxyphenyl)-N-[3-(morpholin-4-yl)propyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide

C066-0833 Screening compound: 2,3-bis(4-methoxyphenyl)-N-[3-(morpholin-4-yl)propyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide
C066-0833 Screening compound: 2,3-bis(4-methoxyphenyl)-N-[3-(morpholin-4-yl)propyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C066-0833
2,3-bis(4-methoxyphenyl)-N-[3-(morpholin-4-yl)propyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C066-0833

Molecular Formula

C31H35N3O5 (C31 H35 N3 O5)

Compound Name

2,3-bis(4-methoxyphenyl)-N-[3-(morpholin-4-yl)propyl]-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide

IUPAC name

23-bis(4-methoxyphenyl)-N-[3-(morpholin-4-yl)propyl]-1-oxo-1234-tetrahydroisoquinoline-4-carboxamide

SMILES

COc1ccc(C(C(C(NCCCN2CCOCC2)=O)c2c3cccc2)N(c(cc2)ccc2OC)C3=O)cc1

InChI

InChI=1S/C31H35N3O5/c1-37-24-12-8-22(9-13-24)29-28(30(35)32-16-5-17-33-18-20-39-21-19-33)26-6-3-4-7-27(26)31(36)34(29)23-10-14-25(38-2)15-11-23/h3-4,6-15,28-29H,5,16-21H2,1-2H3,(H,32,35)

InChI Key

BQVAXSMFEONHTN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14714679

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

529.64

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.245

Distribution Coefficient, logD

2.822

Water Solubility, LogSw

-3.56

Polar Surface Area

66.273

Acid Dissociation Constant (pKa)

12.21

Base Dissociation Constant (pKb)

7.62

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

35.50

C066-0833 in Drug Discovery

Included in Screening Libraries

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with C066-0833 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C066-0833?
Check Price and Availability of C066-0833, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C066-0833 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C066-0833
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C066-0833
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C066-0833 available by request